three years of 503B threads, summarised so you do not have to read them
three years of 503B threads, summarised so you do not have to read them. I have gone back and forth on this for months.
A beyond-use date derived from published stability data means something different from one assigned by default rule. Asking which is a fair question and the answer is usually available.
A 503A pharmacy compounds for an identified patient against a prescription. A 503B outsourcing facility registers with the regulator, may produce without patient-specific prescriptions, and is subject to current good manufacturing practice requirements. The two are governed differently and the difference is not cosmetic.
Compounded preparations are not approved products and carry no bioequivalence claim. That is a statement about regulatory category, not about quality.
If two or three other people have done the same thing we might actually learn something. Alone it is an anecdote.
best — the order this archive was captured in
Nothing in this thread is medical advice, and the choice between arrangements is one for you and a prescriber who knows your history.
Yes — asking which facility, by name, is the single most useful question and most clinics will answer it.
salt forms are the recurring argument and the answer is boring
Yes. The shortage list is the legal hinge for the whole arrangement and its status is public.
Small fix — 503B facilities register with the regulator; 503A pharmacies are licensed by the state board. Different mechanisms.
The shortage list is the legal hinge: the permissions that allow certain compounding to happen at scale are tied to a drug’s shortage status, which changes.
Asked for potency testing on the finished preparation. They had it. I had assumed they would not.
The intake asked me three questions and none of them were about my history. That told me everything I needed to know about the model.
Potency and sterility testing on the finished preparation are separate from any certificate covering the starting material. Ask which you are being shown.
compounded is not generic, there is no equivalence claim
Removed the staff name. Facilities and clinics can be named here; individuals cannot.
Salt form matters for mass: a preparation specified as one salt and dosed as the free base gives you a different amount of peptide for the same number on the label.
a telehealth intake that asks nothing has told you what it is
[deleted]
Kept the label from every vial. When the shortage status changed, having the paper trail made the conversation much shorter.
if a clinic will not name the facility, that is your answer
if a clinic will not name the facility, that is your answer
This is the distinction the whole board runs on. Everything else follows from it.
shortage status changes and the whole arrangement changes with it
Agreed on potency testing of the finished preparation. That is a different question from the purity of the starting material.
the price difference is mostly the intake, not the vial
Same view. If the intake asked you nothing, the intake was a formality and you should factor that in.
Same view.
Agreed — and the follow-up question is what the beyond-use date is based on.
Paid noticeably more at one clinic than another for what turned out to be the same facility behind both.
Asked which facility and got a name straight away. Looked it up, found the registration, felt considerably better about the whole thing.
Cosigning the beyond-use date question. What it is based on tells you whether anybody has done stability work.
Right, and the concentration genuinely can differ from the branded product, which breaks people’s arithmetic.
ask which facility, then ask for their testing
the pharmacy and the prescriber are two separate questions
the shortage list is the whole legal hinge and people skip it
Agreed. The 503A versus 503B distinction changes who is allowed to make what, and almost every confused thread here starts by ignoring it.
- 1if a clinic will not name the facility, that is your answer13 comments in this branch · started by u/lukas_delgado
- 2Asked for potency testing on the finished preparation. They had it. I had…6 comments in this branch · started by u/bilal_osei